Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a dust mine drops; Changhao, an artemisia annua pollen allergen sublingual drops; and Changdian, a dust mite skin prick diagnostic kit. It also involved in the research and development of stem cells and medical artificial intelligence solutions. The company was founded in 2002 and is headquartered in Huzhou, China.

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

He, Jianming

Employees

1,679

Website

www.wolwobiotech.com

IPO Date

2014-01-21

Headquarters

No. 636, Zhiyuan North Road, Wukang Town, Deqing County, Huzhou, Zhejiang Province, 313200, China

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Zhejiang Wolwo Bio-Pharmaceutical 300357

Zhejiang Wolwo Bio-Pharmaceutical Earnings Call Summary

Zhejiang Wolwo Bio-Pharmaceutical Earnings

Transcripts

Events

About Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Zhejiang Wolwo Bio-Pharmaceutical
300357